Clinical Epigenetics, the official journal of the Clinical Epigenetics Society, is an open access, peer-reviewed journal that encompasses all aspects of epigenetic principles and mechanisms, as well as reports on defects of epigenetic regulation, in relation to human disease, diagnosis and therapy. Epigenetic research in disease model organisms is particularly welcome.
Editor-in-Chief
- Ulrich Mahlknecht, St Lukas Clinic, Solingen
Articles
-
Review
Clinical Epigenetics 2012, 4:6 (10 April 2012)A macroepigenetic approach to identify factors responsible for the autism epidemic in the United States
-
Review
Clinical Epigenetics 2012, 4:5 (12 March 2012)Roles of histone deacetylases in epigenetic regulation: emerging paradigms from studies with inhibitors
-
Review
Clinical Epigenetics 2012, 4:4 (27 February 2012)The epigenetic effects of butyrate: potential therapeutic implications for clinical practice
-
Research
Clinical Epigenetics 2012, 4:3 (1 February 2012)Reproducibility and intraindividual variation over days in buccal cell DNA methylation of two asthma genes, interferon γ (IFNγ) and inducible nitric oxide synthase (iNOS)
-
Review
Clinical Epigenetics 2012, 4:2 (30 January 2012)Is Friedreich ataxia an epigenetic disorder?
-
Review
Clinical Epigenetics 2012, 4:1 (20 January 2012)Epigenetic understanding of gene-environment interactions in psychiatric disorders: a new concept of clinical genetics
-
Review
Clinical Epigenetics 2011, 3:9 (5 December 2011)Suffocating cancer: hypoxia-associated epimutations as targets for cancer therapy
- View more articles
Epigenetics news
Society information
The "Clinical Epigenetics Society" (CLEPSO) is a non-profit organization founded at Saarland University.
The society has five main objectives:
- Promotion and support of scientific research projects and initiatives within the field of clinical epigenetics.
- Promotion of the scientific exchange amongst its members.
- Encouragement and support of relations to national and international societies within the area of clinical and translational research.
- Development of an international research and scientific network within the field of clinical epigenetics.
- Providing a forum for encouraging discussions and contributions to the advancement of clinical epigenetics, through the Clinical Epigenetics journal, Blogs, scientific symposia, meetings, and newsletters.
Editor's profile
Ulrich Mahlknecht
Ulrich Mahlknecht is currently a Professor of medicine at the University of Heidelberg, and Head of the Department of Hematology/Oncology at St. Lukas Clinic in Solingen, Germany.
His research focuses on novel targeted immunological and epigenetic concepts in the treatment of solid tumors and hematological malignancies.
Archival content
In October 2011, Clinical Epigenetics became a fully open access journal and is now published as part of BioMed Central's portfolio of journals. To view the journal's content prior to this transition, please see SpringerLink.
Join us on Facebook
Email updates
Receive periodic news and updates relating to this journal.
Indexed by
- Academic OneFile
- CAS
- OCLC
- PubMed
- PubMed Central
- Summon by Serial Solutions